Comparable stake leader
Staffan Encrantz
SEC ownership of Sight Sciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001531177.
Disclosed value leader
KCK LTD.
Comparable rows
50/50
Latest evidence
04 Jun 2026
- Public ticker
- SGHT on Nasdaq
- Parsed ownership sources
- 3/4/5, 13D/G, and 13F
- Largest SEC-reported holder
- Staffan Encrantz
- Latest 13D/G holder
- Staffan Encrantz
- Latest parsed ownership date
- 04 Jun 2026
- Issuer CIK
- 0001531177
- Issuer location
- Menlo Park, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Sight Sciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Staffan Encrantz
Disclosed value leader
KCK LTD.
Comparable rows
50/50
Latest evidence
04 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 13%
13D/G row: Staffan Encrantz
Showing 1-8 of 50 holder rows.
Quick read
Staffan Encrantz leads the comparable SEC ownership view at 13%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Staffan Encrantz's linked filing trail.
Comparable ownership
Top 5
Staffan Encrantz
13%
Long Focus Capital Management, LLC
6%
BlackRock, Inc.
5%
KCK LTD.
2.7%
Paul Badawi
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Staffan Encrantz |
3/4/5
13D/G
Director, 10%+ Owner
|
13%
from 13D/G
|
$24,531,777
6,507,103 shares
|
+$115,963 | 04 Jun 2026 |
| Long Focus Capital Management, LLC |
13F
13D/G
Company
|
6%
from 13D/G
|
$13,549,757
3,594,100 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5%
|
$21,023,667
2,651,156 shares
|
$0 | 31 Dec 2025 |
| KCK LTD. |
3/4/5
13D/G
10%+ Owner
|
2.7%
from 13D/G
|
$24,664,462
4,776,232 shares
|
— | 19 Jul 2021 |
| Paul Badawi |
3/4/5
President and CEO, Director, 10%+ Owner
|
12%
|
$22,759,277
6,151,156 shares
|
-$713,196 | 01 Apr 2026 |
| David Badawi |
3/4/5
Chief Technology Officer, Director
|
3.7%
|
$6,926,209
1,990,290 shares
|
-$177,019 | 02 Apr 2026 |
| Matthew Link |
3/4/5
Chief Commercial Officer
|
1.6%
|
$3,410,736
832,293 shares
|
-$20,035 | 31 Aug 2025 |
| Alison Bauerlein |
3/4/5
Chief Operating Officer
|
1.3%
|
$3,527,132
688,893 shares
|
-$457,331 | 18 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,990,587.
Buys
$233,701
Insiders: 1
Sells
$2,224,288
Insiders: 7
Net
-$1,990,587
Shares: -366,661
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 41,858
Shares: 408,519
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 99,875 | $0 | $376,973 | -$376,973 |
| 3-6 | 13,958 | 120,339 | $115,963 | $877,088 | -$761,125 |
| 6-9 | 0 | 125,680 | $0 | $711,185 | -$711,185 |
| 9-12 | 27,900 | 62,625 | $117,738 | $259,041 | -$141,303 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to Sight Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
KCK LTD.
Net 12M change
-$2,108,325
Latest report
04 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| KCK LTD. | 10%+ Owner | $24,664,462 | Mixed | 19 Jul 2021 | ||
| Staffan Encrantz | Director, 10%+ Owner | $24,531,777 | +$115,963 | +0.47% | Median | 04 Jun 2026 |
| Paul Badawi | President and CEO, Director, 10%+ Owner | $22,759,277 | -$713,196 | -3% | Filing P/S | 01 Apr 2026 |
| D1 Capital Partners L.P. | 10%+ Owner | $17,580,000 | Filing P/S | 27 Dec 2023 | ||
| Andrew Offer | Director | $12,177,869 | Mixed | 19 Jul 2021 | ||
| David Badawi | Chief Technology Officer, Director | $6,926,209 | -$177,019 | -2.5% | Filing P/S | 02 Apr 2026 |
| Alison Bauerlein | Chief Operating Officer | $3,527,132 | -$457,331 | -11% | Filing P/S | 18 May 2026 |
| Matthew Link | Chief Commercial Officer | $3,410,736 | -$20,035 | -0.58% | Filing P/S | 31 Aug 2025 |
| Jesse Selnick | Chief Financial Officer | $2,082,946 | Mixed | 01 Jan 2023 | ||
| Sam Boong Park | Chief Operating Officer | $1,549,342 | Filing P/S | 01 Oct 2024 | ||
| Jeremy B. Hayden | Chief Legal Officer | $1,312,683 | -$635,027 | -33% | Filing P/S | 06 Apr 2026 |
| Brenton Taylor | EVP, Operations & R&D | $990,885 | -$119,028 | -11% | Filing P/S | 01 Apr 2026 |
| James Rodberg | Chief Financial Officer | $819,833 | -$102,652 | -11% | Filing P/S | 06 Apr 2026 |
| Donald Zurbay | Director | $729,921 | Median | 04 Jun 2026 | ||
| Erica J. Rogers | Director | $564,633 | Mixed | 05 Jun 2025 | ||
| Manohar K. Raheja | EVP, Research & Development | $506,320 | Mixed | 31 Aug 2025 | ||
| Gerhard F. Burbach | Director | $464,490 | Median | 04 Jun 2026 | ||
| Tamara Fountain | Director | $413,380 | Median | 04 Jun 2026 | ||
| Catherine Mazzacco | Director | $402,514 | Median | 04 Jun 2026 | ||
| Brenda Larsen-Becker | Director | $254,508 | Mixed | 05 Jun 2025 |
Recent insider transactions for Sight Sciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Tamara Fountain | SGHT | Common Stock | Award | 34.7% | 28,261 | 109,650 | 04 Jun 2026 | Direct | ||
| Staffan Encrantz | SGHT | Common Stock | Award | 2.03% | 28,261 | 1,420,183 | 04 Jun 2026 | Direct | ||
| Gerhard F. Burbach | SGHT | Common Stock | Award | 29.8% | 28,261 | 123,207 | 04 Jun 2026 | Direct | ||
| Donald Zurbay | SGHT | Common Stock | Award | 17.1% | 28,261 | 193,613 | 04 Jun 2026 | Direct | ||
| Catherine Mazzacco | SGHT | Common Stock | Award | 68.9% | 28,261 | 69,276 | 04 Jun 2026 | Direct | ||
| Alison Bauerlein | SGHT | Common Stock | Sale | -1.81% | $65,167 | $5.12 | -12,728 | 688,893 | 18 May 2026 | Direct |
| James Rodberg | SGHT | Common Stock | Sale | -3.04% | $25,670 | $3.55 | -7,231 | 230,939 | 06 Apr 2026 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -3.59% | $48,852 | $3.55 | -13,761 | 369,770 | 06 Apr 2026 | Direct |
| Alison Bauerlein | SGHT | Common Stock | Sale | -3.56% | $90,042 | $3.48 | -25,874 | 701,621 | 02 Apr 2026 | Direct |
| David Badawi | SGHT | Common Stock | Sale | -0.41% | $28,425 | $3.48 | -8,168 | 1,990,290 | 02 Apr 2026 | Direct |
| Brenton Taylor | SGHT | Common Stock | Sale | -1.06% | $10,615 | $3.70 | -2,869 | 267,807 | 01 Apr 2026 | Direct |
| Paul Badawi | SGHT | Common Stock | Sale | -0.47% | $108,203 | $3.70 | -29,244 | 6,151,156 | 01 Apr 2026 | Direct |
| David Badawi | SGHT | Common Stock | Options Exercise | 1.08% | 21,270 | 1,998,458 | 19 Feb 2026 | Direct | ||
| David Badawi | SGHT | Stock Option (Right to Buy) | Options Exercise | -100% | -21,270 | 0 | 19 Feb 2026 | Direct | ||
| David Badawi | SGHT | Common Stock | Award | 3.39% | 64,915 | 1,977,188 | 03 Feb 2026 | Direct | ||
| Jeremy B. Hayden | SGHT | Common Stock | Award | 43.3% | 115,920 | 383,531 | 03 Feb 2026 | Direct | ||
| Alison Bauerlein | SGHT | Common Stock | Award | 21.2% | 127,512 | 727,495 | 03 Feb 2026 | Direct | ||
| Paul Badawi | SGHT | Common Stock | Award | 2.56% | 154,560 | 6,180,400 | 03 Feb 2026 | Direct | ||
| James Rodberg | SGHT | Common Stock | Award | 57.5% | 86,940 | 238,170 | 03 Feb 2026 | Direct | ||
| Brenton Taylor | SGHT | Common Stock | Award | 59% | 100,464 | 270,676 | 03 Feb 2026 | Direct | ||
| David Badawi | SGHT | Common Stock | Sale | -0.25% | $32,014 | $6.62 | -4,836 | 1,912,273 | 16 Jan 2026 | Direct |
| James Rodberg | SGHT | Common Stock | Sale | -1.7% | $17,318 | $6.62 | -2,616 | 151,230 | 16 Jan 2026 | Direct |
| Paul Badawi | SGHT | Common Stock | Sale | -0.37% | $148,036 | $6.62 | -22,362 | 6,025,840 | 16 Jan 2026 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -2.3% | $41,759 | $6.62 | -6,308 | 267,611 | 16 Jan 2026 | Direct |
| Paul Badawi | SGHT | Common Stock | Sale | -0.2% | $88,788 | $7.48 | -11,870 | 5,925,276 | 06 Jan 2026 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -0.72% | $13,352 | $7.48 | -1,785 | 245,420 | 06 Jan 2026 | Direct |
| David Badawi | SGHT | Common Stock | Sale | -0.19% | $27,639 | $7.48 | -3,695 | 1,917,109 | 06 Jan 2026 | Direct |
| James Rodberg | SGHT | Common Stock | Sale | -0.38% | $4,443 | $7.48 | -594 | 153,846 | 06 Jan 2026 | Direct |
| Alison Bauerlein | SGHT | Common Stock | Sale | -1.58% | $72,160 | $7.48 | -9,647 | 599,983 | 06 Jan 2026 | Direct |
| Brenton Taylor | SGHT | Common Stock | Sale | -0.36% | $4,630 | $7.48 | -619 | 170,212 | 06 Jan 2026 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -3.66% | $73,391 | $7.82 | -9,385 | 247,205 | 05 Jan 2026 | Direct |
| David Badawi | SGHT | Common Stock | Sale | -0.16% | $23,859 | $7.82 | -3,051 | 1,920,804 | 05 Jan 2026 | Direct |
| James Rodberg | SGHT | Common Stock | Sale | -2.77% | $34,447 | $7.82 | -4,405 | 154,440 | 05 Jan 2026 | Direct |
| Alison Bauerlein | SGHT | Common Stock | Sale | -1.76% | $85,207 | $7.82 | -10,896 | 609,630 | 05 Jan 2026 | Direct |
| Paul Badawi | SGHT | Common Stock | Sale | -0.43% | $188,395 | $7.43 | -25,356 | 5,937,146 | 02 Jan 2026 | Direct |
| David Badawi | SGHT | Common Stock | Sale | -0.15% | $21,651 | $7.43 | -2,914 | 1,923,855 | 02 Jan 2026 | Direct |
| David Badawi | SGHT | Common Stock | Options Exercise | 1.12% | 21,270 | 1,926,769 | 26 Dec 2025 | Direct | ||
| David Badawi | SGHT | Stock Option (Right to Buy) | Options Exercise | -50% | -21,270 | 21,270 | 26 Dec 2025 | Direct | ||
| Staffan Encrantz | SGHT | Common Stock | Purchase | 1.01% | $115,963 | $8.31 | 13,958 | 1,391,922 | 16 Dec 2025 | Direct |
| James Rodberg | SGHT | Common Stock | Sale | -1.56% | $20,774 | $8.25 | -2,518 | 158,845 | 02 Dec 2025 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -14.9% | $362,388 | $8.08 | -44,850 | 256,590 | 25 Nov 2025 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Options Exercise | 17.5% | 44,850 | 301,440 | 25 Nov 2025 | Direct | ||
| Jeremy B. Hayden | SGHT | Stock Option (Right to Buy) | Options Exercise | -84.9% | -44,850 | 8,000 | 25 Nov 2025 | Direct | ||
| Brenton Taylor | SGHT | Common Stock | Sale | -7.78% | $101,791 | $7.06 | -14,418 | 170,831 | 17 Nov 2025 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Sale | -1.21% | $25,232 | $8.01 | -3,150 | 256,590 | 12 Nov 2025 | Direct |
| Jeremy B. Hayden | SGHT | Common Stock | Options Exercise | 1.23% | 3,150 | 259,740 | 12 Nov 2025 | Direct | ||
| Jeremy B. Hayden | SGHT | Stock Option (Right to Buy) | Options Exercise | -100% | -3,150 | 0 | 12 Nov 2025 | Direct | ||
| Alison Bauerlein | SGHT | Common Stock | Award | 3.85% | 23,006 | 620,526 | 11 Nov 2025 | Direct | ||
| James Rodberg | SGHT | Common Stock | Award | 10.5% | 15,337 | 161,363 | 11 Nov 2025 | Direct | ||
| Brenton Taylor | SGHT | Common Stock | Sale | -0.32% | $1,992 | $3.37 | -591 | 185,249 | 06 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.